These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3870142)

  • 1. Principia of cancer therapy. X. Prostaglandin D2 triggers redifferentiation of the bestatin-treated breast cancer cells in vitro.
    Okuyama S; Mishina H
    Sci Rep Res Inst Tohoku Univ Med; 1985 Dec; 32(1-4):31-4. PubMed ID: 3870142
    [No Abstract]   [Full Text] [Related]  

  • 2. Principia of cancer therapy. XI. Prostaglandin D2 induces redifferentiation of M1 leukemia cells in vitro irrespective of bestatin.
    Okuyama S; Mishina H
    Sci Rep Res Inst Tohoku Univ Med; 1985 Dec; 32(1-4):35-8. PubMed ID: 3870143
    [No Abstract]   [Full Text] [Related]  

  • 3. Redifferentiation of cancer cells: bestatin, estradiol, and prostaglandin D2.
    Okuyama S; Mishina H; Maki T
    Ann N Y Acad Sci; 1985; 459():293-307. PubMed ID: 3868328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antineoplastic action of prostaglandin D2--effect of PGD2 on proliferation of L1210 leukemic cells in culture].
    Fukushima M; Kato T; Ota K
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):159-60. PubMed ID: 6964030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decrease in saturation density of mammalian carcinoma cell culture during exposure to bestatin, a clinically applicable agent.
    Okuyama S; Mishina H
    Tohoku J Exp Med; 1984 Mar; 142(3):349-50. PubMed ID: 6729813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor differentiation--application of prostaglandins in the treatment of neuroblastoma.
    Imashuku S; Todo S; Esumi N; Hashida T; Tsunamoto K; Nakajima F
    Prog Clin Biol Res; 1985; 175():89-98. PubMed ID: 2986176
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of prostaglandin (delta 12-PGJ2) on host immunity--an experimental study].
    Matsuura H; Imaya H
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1936-7. PubMed ID: 3592721
    [No Abstract]   [Full Text] [Related]  

  • 8. Principia of cancer therapy VII. Tetracyclines as cancer antagonists.
    Okuyama S; Mishina H; Takahashi K
    Sci Rep Res Inst Tohoku Univ Med; 1984 Oct; 31(1-4):27-9. PubMed ID: 6098965
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the mechanisms of action of the immunomodulator Bestatin in various screening test systems.
    Schorlemmer HU; Bosslet K; Dickneite G; Lüben G; Sedlacek HH
    Behring Inst Mitt; 1984 May; (74):157-73. PubMed ID: 6383322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Principia of cancer therapy. III. Perpetuation principle of repairable chemotherapeutic damage: cisplatin-bleomycin in vitro.
    Okuyama S; Mishina H
    Sci Rep Res Inst Tohoku Univ Med; 1983 Dec; 30(1-4):5-7. PubMed ID: 6205446
    [No Abstract]   [Full Text] [Related]  

  • 11. In vivo effects of prostaglandins on human retinoblastoma cells in nude mice.
    Nakamura M; Fujino Y; Mochizuki M; Minoda K; Masuda K
    Jpn J Ophthalmol; 1987; 31(4):608-20. PubMed ID: 3482290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines.
    Glinsky GV; Price JE; Glinsky VV; Mossine VV; Kiriakova G; Metcalf JB
    Cancer Res; 1996 Dec; 56(23):5319-24. PubMed ID: 8968076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ability of the immunomodulating dipeptide bestatin to activate cytotoxic mononuclear phagocytes.
    Schorlemmer HU; Bosslet K; Sedlacek HH
    Cancer Res; 1983 Sep; 43(9):4148-53. PubMed ID: 6871856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Differentiation induction and potentiation of chemotherapy by PGE1 infusion in patients with neuroblastoma--effect of PGE1 on metastatic potential of neuroblastoma].
    Imashuku S; Esumi N; Todo S; Nakajima F
    Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):775-80. PubMed ID: 6585182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of neuroendocrine hormones on human ovarian cancer cell proliferation in vitro.
    Kikuchi Y; Kita T; Miyauchi M; Oomori K; Kizawa I; Iwano I; Kato K
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Sep; 39(9):1653-4. PubMed ID: 3479504
    [No Abstract]   [Full Text] [Related]  

  • 16. Consecutive bestatin-hormone regimen induces redifferentiation of cancer cells in vitro.
    Okuyama S; Mishina H
    Tohoku J Exp Med; 1984 Aug; 143(4):501-2. PubMed ID: 6495327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cell differentiation of Ehrlich ascites cancer cultured outside of the body].
    Shuklinov VA; Shumilina VV
    Dokl Akad Nauk SSSR; 1982; 262(1):222-5. PubMed ID: 7060443
    [No Abstract]   [Full Text] [Related]  

  • 18. Prostaglandin-induced differentiation or dimethyl sulfoxide-induced differentiation: reduction of the neoplastic potential of a rat mammary tumor stem-cell line.
    Rudland PS; Davies AT; Warburton MJ
    J Natl Cancer Inst; 1982 Nov; 69(5):1083-93. PubMed ID: 6957654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haploid inactivation of the amplified-in-breast cancer 3 coactivator reduces the inhibitory effect of peroxisome proliferator-activated receptor gamma and retinoid X receptor on cell proliferation and accelerates polyoma middle-T antigen-induced mammary tumorigenesis in mice.
    Zhang H; Kuang SQ; Liao L; Zhou S; Xu J
    Cancer Res; 2004 Oct; 64(19):7169-77. PubMed ID: 15466215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
    D'Amico M; Wu K; Di Vizio D; Reutens AT; Stahl M; Fu M; Albanese C; Russell RG; Muller WJ; White M; Negassa A; Lee HW; DePinho RA; Pestell RG
    Cancer Res; 2003 Jun; 63(12):3395-402. PubMed ID: 12810676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.